These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3653579)

  • 21. [Anticoagulant prophylaxis: from clinical trials to clinical practice].
    Scardi S; Mazzone C
    G Ital Cardiol; 1998 Feb; 28(2):178-86. PubMed ID: 9534059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
    Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
    Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulant prophylaxis and epidural catheter removal.
    Wu CL; Perkins FM
    Reg Anesth; 1996; 21(6):517-24. PubMed ID: 8956387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Self testing and self management of oral anticoagulants with warfarin].
    Nadav L; Schwartz J
    Harefuah; 2003 Sep; 142(8-9):621-3, 645, 644. PubMed ID: 14518167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of oral anticoagulant treatment on D-dimers levels].
    Ombandza-Moussa E; Samama MM; Horellou MH; Chatelier AL; Elalamy I; Conard J
    Ann Biol Clin (Paris); 2001; 59(5):579-83. PubMed ID: 11602388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral anticoagulation of ambulatory patients (author's transl)].
    Biland L; Rüst O; Nyman D; Duckert F
    Schweiz Rundsch Med Prax; 1974 Dec; 63(52):1568-72. PubMed ID: 4445103
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Gensini GF; Abbate R; Prisco D
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):491-4. PubMed ID: 16175008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral anticoagulation therapy in the primary care setting].
    Vinker S; Nakar S; Finkel S; Nir E; Hyam E
    Harefuah; 1997 Jun; 132(11):753-6, 824, 823. PubMed ID: 9223814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma concentration of oral anticoagulants--a clinically useful analysis].
    Ivermark CK; Orme M
    Lakartidningen; 1980 May; 77(20):1943-4. PubMed ID: 7392729
    [No Abstract]   [Full Text] [Related]  

  • 34. [An outpatient regimen for dental improvements in patients with valvular cardiopathies and oral anticoagulant therapy (a preliminary note)].
    Cesareo BV; Pettini M; Soreca G; Agostino R; Batoni L; Mancini G; Vannini AM; Sabatini L; Bertelli E
    Minerva Stomatol; 1994 Sep; 43(9):409-15. PubMed ID: 7816015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
    Turpie AG
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point-of-care testing in oral anticoagulation: what is the point?
    Katz B; Marques MB
    MLO Med Lab Obs; 2004 Mar; 36(3):30-5. PubMed ID: 15061055
    [No Abstract]   [Full Text] [Related]  

  • 39. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
    Scardi S; Giansante C
    Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting oral anticoagulation.
    Weiner M
    Clin Pharmacol Ther; 2000 Jul; 68(1):4-5. PubMed ID: 10945309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.